Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure

Summary

The objective of this study is to determine the safety and effectiveness of intrarenal administration of brain natriuretic peptide (BNP) in improving renal function as measured by glomerular filtration rate (GFR) and sodium excretion in patients hospitalized with acute congestive heart failure (CHF) and deterioration of kidney function (cardiorenal syndrome).

Timeline

Start

2005-12

Primary completion

2010-03

Completion

2010-03

Outcome

Outcome not reported

Stopped (Business): “Company providing catheter bought out, funding and supplies terminated”

Drugs

Indications